0001978126-24-000001.txt : 20240813 0001978126-24-000001.hdr.sgml : 20240813 20240813144017 ACCESSION NUMBER: 0001978126-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240813 DATE AS OF CHANGE: 20240813 EFFECTIVENESS DATE: 20240813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Convergent Therapeutics, Inc. CENTRAL INDEX KEY: 0001978126 ORGANIZATION NAME: IRS NUMBER: 852703536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-521383 FILM NUMBER: 241200671 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-710-4289 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001978126 Convergent Therapeutics, Inc. ONE BROADWAY 14TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 617-710-4289 DELAWARE None None Corporation true 2020 Philip Kantoff One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Alexander Brown One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Neil Bander One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Tal Zaks One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Jake Simson One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Eric Sullivan One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Jim Trenkle One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2024-07-31 false true false 0 39999996 22222220 17777776 false 1 0 0 0 false Convergent Therapeutics, Inc. Philip Kantoff Philip Kantoff CEO 2024-08-13